RBC Capital Reiterates Outperform on Inspire Medical Systems, Maintains $260 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Inspire Medical Systems (NYSE:INSP) and maintained a price target of $260.
August 07, 2024 | 4:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Inspire Medical Systems (NYSE:INSP) and maintained a price target of $260.
The reiteration of an Outperform rating and a maintained price target of $260 by RBC Capital is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100